Balance Sheet Details

3 Months Ended

Mar. 31, 2024

Balance Sheet Details

Balance Sheet Details

6. Balance Sheet Details

Property and Equipment

Property and equipment as of March 31, 2024 and December 31, 2023 consisted of the following:

	March 31, 2024		December 31, 2023
Laboratory equipment	$	20,136	$	19,678
Furniture and fixtures		817		817
Office and computer equipment		438		438
Leasehold improvements		3,447		3,447
Total		24,838		24,380
Less: accumulated depreciation		(12,138)		(11,821)
Property and equipment, net	$	12,700	$	12,559

Depreciation and amortization expense totaled $0.3 million and $0.2 million for the three months ended March 31, 2024 and 2023, respectively. Construction in progress and fixed assets not in use were $8.5 million and $8.1 million as of March 31, 2024 and December 31, 2023, respectively, and are included in the laboratory and manufacturing equipment in the table above. These assets are not depreciated until they are placed in service.

Other receivables

Other receivables as of March 31, 2024 and December 31, 2023 consisted of the following:

	March 31, 2024		December 31, 2023
Tenant improvement allowance receivable (Note 12)	$	748	$	1,835
Grant and award receivable		966		1,528
	$	1,714	$	3,363

Accounts payable and accrued liabilities

Accounts payable and accrued liabilities as of March 31, 2024 and December 31, 2023 consisted of the following:

	March 31, 2024		December 31, 2023
Accounts payable	$	2,057	$	1,585
Accrued clinical trial expenses		1,817		3,021
Other accrued expenses		736		1,083
	$	4,610	$	5,689